HistCite - DE Kuhl w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
201	12468 Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, et al. Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (3): 843-854	0	0	38	106
202	951 HEISS WD EMISSION TOMOGRAPHY OF THE BRAIN WIENER KLINISCHE WOCHENSCHRIFT. 1981; 93 (12): 371-376	1	2	37	74
203	3455 ANTAR MA RADIOPHARMACEUTICALS FOR STUDYING CARDIAC METABOLISM NUCLEAR MEDICINE AND BIOLOGY. 1990; 17 (1): 103-&	2	16	37	157
204	3713 KUWERT T, LANGE HW, LANGEN KJ, HERZOG H, AULICH A, et al. CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTONS-DISEASE BRAIN. 1990 OCT; 113: 1405-1423	99	153	37	78
205	5076 THEODORE WH INSIGHTS FROM FUNCTIONAL NEUROIMAGING IN THE LOCALIZATION AND DEFINITION OF FOCAL EPILEPSY CLINICAL NEUROSCIENCE. 1994; 2 (1): 89-95	1	2	37	78
206	5515 BUCHSBAUM MS POSITRON EMISSION TOMOGRAPHY STUDIES OF ABNORMAL GLUCOSE-METABOLISM IN SCHIZOPHRENIC ILLNESS CLINICAL NEUROSCIENCE. 1995; 3 (2): 122-130	3	11	37	75
207	5769 DEVOUS MD SPECT FUNCTIONAL BRAIN IMAGING JOURNAL OF NEUROIMAGING. 1995 JUL; 5: S2-S13	3	7	37	88
208	6965 Rauch SL, Savage CR Neuroimaging and neuropsychology of the striatum - Bridging basic science and clinical practice PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 DEC; 20 (4): 741-+	1	59	37	193
209	7641 Teipel SJ, Hampel H, Pietrini P, Moller HJ, Rapoport SI PET in Alzheimer's disease - From resting-state to activation studies DRUG NEWS & PERSPECTIVES. 1999 MAR; 12 (2): 83-90	1	2	37	73
210	9766 Asenbaum S PET and SPECT investigations in Alzheimer's disease RADIOLOGE. 2003 JUL; 43 (7): 521-+	0	0	37	56
#	Date / Author / Journal	LCS	GCS	LCR	CR
211	10305 Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowsey P PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences NEUROIMAGE. 2004 SEP; 23 (1): 1-16	2	26	37	198
212	10479 Koepp MJ, Woermann FG Imaging structure and function in refractory focal epilepsy LANCET NEUROLOGY. 2005 JAN; 4 (1): 42-53	7	32	37	151
213	10493 D'Souza I, Schellenberg GD Regulation of tau isoform expression and dementia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 104-115	2	43	37	117
214	11108 Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2006 SEP; 26 (9): 1198-1212	24	45	37	112
215	11141 Chetelat G, Desgranges B, Eustache F Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy. REVUE NEUROLOGIQUE. 2006 OCT; 162 (10): 945-951	3	10	37	72
216	11344 Kopp MJ PET tracer technology for monitoring focal epilepsies EXPERT REVIEW OF MEDICAL DEVICES. 2007 MAR; 4 (2): 191-200	0	0	37	103
217	11686 Herholz K Imaging of dementia DISEASES OF THE BRAIN, HEAD & NECK, SPINE. 2008; : 215-218	0	0	37	62
218	12230 Lalonde L, Ziadi MC, Beanlands R Cardiac Positron Emission Tomography: Current Clinical Practice CARDIOLOGY CLINICS. 2009 MAY; 27 (2): 237-+	1	2	37	87
219	12508 Kim S, Salamon N, Jackson HA, Bluml S, Panigrahy A PET imaging in pediatric neuroradiology: current and future applications PEDIATRIC RADIOLOGY. 2010 JAN; 40 (1): 82-96	0	0	37	114
220	2039 CORREIA JA, ALPERT NM POSITRON EMISSION TOMOGRAPHY IN CARDIOLOGY RADIOLOGIC CLINICS OF NORTH AMERICA. 1985; 23 (4): 783-793	0	0	36	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
221	3752 GZESH D, GOLDSTEIN S, SPERLING MR, ALAVI A COMPLEX PARTIAL EPILEPSY - THE ROLE OF NEUROIMAGING IN LOCALIZING A SEIZURE FOCUS FOR SURGICAL INTERVENTION JOURNAL OF NUCLEAR MEDICINE. 1990 NOV; 31 (11): 1839-1843	1	7	36	64
222	3805 FRISTON KJ, FRACKOWIAK RSJ CEREBRAL FUNCTION IN AGING AND ALZHEIMERS-DISEASE - THE ROLE OF PET ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY. 1991; : 355-365	0	0	36	55
223	3952 SCHWAIGER M, HICKS R THE CLINICAL ROLE OF METABOLIC IMAGING OF THE HEART BY POSITRON EMISSION TOMOGRAPHY JOURNAL OF NUCLEAR MEDICINE. 1991 APR; 32 (4): 565-578	30	111	36	101
224	3953 GOULD KL PET PERFUSION IMAGING AND NUCLEAR CARDIOLOGY JOURNAL OF NUCLEAR MEDICINE. 1991 APR; 32 (4): 579-606	18	52	36	150
225	4042 CLEGHORN JM, ZIPURSKY RB, LIST SJ STRUCTURAL AND FUNCTIONAL BRAIN IMAGING IN SCHIZOPHRENIA JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 1991 JUL; 16 (2): 53-74	4	25	36	180
226	4170 WYLER AR SURGICAL-TREATMENT OF TEMPORAL-LOBE EPILEPSY NEUROSURGERY QUARTERLY. 1991 DEC; 1 (4): 214-232	1	2	36	154
227	5074 HAWKINS RA, HOH C, GLASPY J, REGE S, CHOI Y, et al. POSITRON EMISSION TOMOGRAPHY SCANNING IN CANCER CANCER INVESTIGATION. 1994; 12 (1): 74-87	4	21	36	99
228	5098 BARON JC CONSEQUENCES OF LESIONS OF THE BASAL GANGLIA ON BRAIN METABOLIC- ACTIVITY - CLINICAL CORRELATIONS REVUE NEUROLOGIQUE. 1994; 150 (8-9): 599-604	2	8	36	61
229	7073 Nguyen DK, Botez MI Diaschisis and neurobehavior CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 1998 FEB; 25 (1): 5-12	1	32	36	102
230	7517 Inoue O, Kobayashi K, Gee A Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments CRITICAL REVIEWS IN NEUROBIOLOGY. 1999; 13 (2): 199-225	3	12	36	191
#	Date / Author / Journal	LCS	GCS	LCR	CR
231	8315 Gibson RE, Burns HD, Hamill TG, Eng WS, Francis BE, et al. Non-invasive radiotracer imaging as a tool for drug development CURRENT PHARMACEUTICAL DESIGN. 2000 JUL; 6 (10): 973-989	7	46	36	117
232	9173 Schmidt KC, Turkheimer FE Kinetic modeling in positron emission tomography QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 2002 MAR; 46 (1): 70-85	9	24	36	80
233	9243 Hutchinson PJ, O'Connell MT, Kirkpatrick PJ, Pickard JD How can we measure substrate, metabolite and neurotransmitter concentrations in the human brain? PHYSIOLOGICAL MEASUREMENT. 2002 MAY; 23 (2): R75-R109	0	13	36	264
234	9843 Akanuma N, Koutroumanidis M, Adachi N, Alarcon G, Binnie CD Presurgical assessment of memory-related brain structures: the Wada test and functional neuroimaging SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2003 SEP; 12 (6): 346-358	2	12	36	135
235	10371 Shiue CY, Welch MJ Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose RADIOLOGIC CLINICS OF NORTH AMERICA. 2004 NOV; 42 (6): 1033-+	3	10	36	246
236	10485 Silverman DHS, Alavi A PET imaging in the assessment of normal and impaired cognitive function RADIOLOGIC CLINICS OF NORTH AMERICA. 2005 JAN; 43 (1): 67-+	2	8	36	78
237	11247 Gasparini L, Terni B, Spillantini MG Frontotemporal dementia with tau pathology NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 236-253	1	21	36	157
238	11725 Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimers disease BRAIN. 2008 JAN; 131: 60-71	14	43	36	81
239	12260 Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, et al. Amyloid PET and MRI in Alzheimer's Disease and Mild Cognitive Impairment CURRENT ALZHEIMER RESEARCH. 2009 JUN; 6 (3): 312-319	0	3	36	91
240	12613 Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, et al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages BRAIN STRUCTURE & FUNCTION. 2010 MAY; 214 (4): 303-317	0	0	36	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
241	2549 SCHELBERT HR, SCHWAIGER M POSITRON EMISSION TOMOGRAPHY IN HUMAN MYOCARDIAL-ISCHEMIA HERZ. 1987 FEB; 12 (1): 22-40	3	7	35	92
242	2923 HENDEE WR APPLICATION OF POSITRON EMISSION TOMOGRAPHY IN THE HEART JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1988 APR 22; 259 (16): 2438-2445	0	3	35	73
243	5334 WITTE OW, BRUEHL C, SCHLAUG G, TUXHORN I, LAHL R, et al. DYNAMIC CHANGES OF FOCAL HYPOMETABOLISM IN RELATION TO EPILEPTIC ACTIVITY JOURNAL OF THE NEUROLOGICAL SCIENCES. 1994 JUL; 124 (2): 188-197	14	33	35	61
244	5558 GAILLARD WD, WHITE S, MALOW B, FLAMINI R, WEINSTEIN S, et al. FDG-PET IN CHILDREN AND ADOLESCENTS WITH PARTIAL SEIZURES - ROLE IN EPILEPSY SURGERY EVALUATION EPILEPSY RESEARCH. 1995 JAN; 20 (1): 77-84	20	39	35	64
245	6024 Camici PG, Gropler RJ, Jones T, LAbbate A, Maseri A, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases EUROPEAN HEART JOURNAL. 1996 JAN; 17 (1): 25-34	13	38	35	95
246	7113 Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, et al. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: Analysis of the FDG lumped constant JOURNAL OF NUCLEAR MEDICINE. 1998 MAR; 39 (3): 440-448	32	54	35	82
247	8513 Forman MS, Lee VMY, Trojanowski JQ New insights into genetic and molecular mechanisms of brain degeneration in tauopathies JOURNAL OF CHEMICAL NEUROANATOMY. 2000 DEC; 20 (3-4): 225-244	4	32	35	191
248	9159 Langer O, Halldin C PET and SPET tracers for mapping the cardiac nervous system EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2002 MAR; 29 (3): 416-434	4	26	35	193
249	10077 Bartenstein P PET in neuroscience - Dopaminergic, GABA/benzodiazepine, and opiate system NUKLEARMEDIZIN-NUCLEAR MEDICINE. 2004 FEB; 43 (1): 33-42	1	5	35	121
250	10495 Brandt R, Hundelt M, Shahani N Tau alteration and neuronal degeneration in tauopathies: mechanisms and models BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 331-354	1	64	35	228
#	Date / Author / Journal	LCS	GCS	LCR	CR
251	10568 Ito H, Kanno I, Fukuda H Human cerebral circulation: positron emission tomography studies ANNALS OF NUCLEAR MEDICINE. 2005 APR; 19 (2): 65-74	0	22	35	136
252	10850 Eckelman WC Imaging of muscarinic receptors in the central nervous system CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (30): 3901-3913	0	8	35	108
253	10923 Slart RHJA, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RAJO, et al. Imaging techniques in nuclear cardiology for the assessment of myocardial viability INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING. 2006 FEB; 22 (1): 63-80	1	20	35	137
254	12216 Borghammer P, Cumming P, Aanerud J, Gjedde A Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease NEUROIMAGE. 2009 APR 1; 45 (2): 249-257	4	12	35	78
255	2383 FEENEY DM, BARON JC DIASCHISIS STROKE. 1986 SEP-OCT; 17 (5): 817-830	125	508	34	206
256	3035 MAURER AH NUCLEAR-MEDICINE - SPECT COMPARISONS TO PET RADIOLOGIC CLINICS OF NORTH AMERICA. 1988 SEP; 26 (5): 1059-1074	11	25	34	63
257	3134 TEWSON TJ PROCEDURES, PITFALLS AND SOLUTIONS IN THE PRODUCTION OF [F-18]2-DEOXY- 2-FLUORO-D-GLUCOSE - A PARADIGM IN THE ROUTINE SYNTHESIS OF F-18 RADIOPHARMACEUTICALS NUCLEAR MEDICINE AND BIOLOGY. 1989; 16 (6): 533-551	10	25	34	93
258	5470 MAYBERG HS CLINICAL CORRELATES OF PET-IDENTIFIED AND SPECT-IDENTIFIED DEFECTS IN DEMENTIA JOURNAL OF CLINICAL PSYCHIATRY. 1994 NOV; 55: 12-21	7	24	34	89
259	8298 Brinkmann BH, O'Brien TJ, Mullan BP, O'Connor MK, Robb RA, et al. Subtraction ictal SPECT coregistered to MRI for seizure focus localization in partial epilepsy MAYO CLINIC PROCEEDINGS. 2000 JUN; 75 (6): 615-624	1	12	34	104
260	9327 Salmon E Functional brain imaging applications to differential diagnosis in the dementias CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 439-444	3	7	34	70
#	Date / Author / Journal	LCS	GCS	LCR	CR
261	9968 Shinotoh H, Fukushi K, Nagatsuka S, Irie T Acetylcholinesterase imaging: Its use in therapy evaluation and drug design CURRENT PHARMACEUTICAL DESIGN. 2004; 10 (13): 1505-1517	7	16	34	69
262	10094 Farias ST, Jagust WJ Neuroimaging in non-Alzheimer dementias CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 383-395	0	0	34	133
263	10552 Pakrasi S, O'Brien JT Emission tomography in dementia NUCLEAR MEDICINE COMMUNICATIONS. 2005 MAR; 26 (3): 189-196	3	16	34	102
264	11180 Hammers A, Lingford-Hughes A Opioid imaging NEUROIMAGING CLINICS OF NORTH AMERICA. 2006 NOV; 16 (4): 529-+	1	5	34	135
265	11481 Cohen RM The application of positron-emitting molecular imaging tracers in Alzheimer's disease MOLECULAR IMAGING AND BIOLOGY. 2007 JUL-AUG; 9 (4): 204-216	3	10	34	130
266	12132 Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging NEUROIMAGE. 2009 JAN 1; 44 (1): 43-50	10	14	34	49
267	12231 Schelbert HR Quantification of Myocardial Blood Flow: What is the Clinical Role? CARDIOLOGY CLINICS. 2009 MAY; 27 (2): 277-+	1	5	34	80
268	12309 Borghammer P, Aanerud J, Gjedde A Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization NEUROIMAGE. 2009 JUL 15; 46 (4): 981-988	1	2	34	64
269	12416 Saft C, Kosinski CM, Landwehrmeyer GB Progress in Premanifest and Manifest Diagnostics in Huntington's Disease AKTUELLE NEUROLOGIE. 2009 DEC; 36 (10): 506-+	1	1	34	250
270	12439 Tateno M, Kobayashi S, Saito T Imaging Improves Diagnosis of Dementia with Lewy Bodies PSYCHIATRY INVESTIGATION. 2009 DEC; 6 (4): 233-240	0	0	34	97
#	Date / Author / Journal	LCS	GCS	LCR	CR
271	12766 Schweitzer PJ, Fallon BA, Mann JJ, Kumar JSD PET tracers for the peripheral benzodiazepine receptor and uses thereof DRUG DISCOVERY TODAY. 2010 NOV; 15 (21-22): 933-942	0	0	34	98
272	3502 LEENDERS KL, PERANI D, LAMMERTSMA AA, HEATHER JD, BUCKINGHAM P, et al. CEREBRAL BLOOD-FLOW, BLOOD-VOLUME AND OXYGEN UTILIZATION - NORMAL VALUES AND EFFECT OF AGE BRAIN. 1990 FEB; 113: 27-47	92	440	33	60
273	4551 VOLKOW ND, FOWLER JS NEUROPSYCHIATRIC DISORDERS - INVESTIGATION OF SCHIZOPHRENIA AND SUBSTANCE-ABUSE SEMINARS IN NUCLEAR MEDICINE. 1992 OCT; 22 (4): 254-267	9	28	33	96
274	5103 HOH CK, DAHLBOM M, HAWKINS RA, GLASPY JA, YAO WJ, et al. BASIC PRINCIPLES OF POSITRON EMISSION TOMOGRAPHY IN ONCOLOGY - QUANTITATION AND WHOLE-BODY TECHNIQUES WIENER KLINISCHE WOCHENSCHRIFT. 1994; 106 (15): 496-504	4	7	33	102
275	5374 MOERLEIN SM, PERLMUTTER JS, WELCH MJ, RAICHLE ME FIRST-PASS EXTRACTION FRACTION OF I-123 LABELED PERFUSION TRACERS IN LIVING PRIMATE BRAIN NUCLEAR MEDICINE AND BIOLOGY. 1994 AUG; 21 (6): 847-855	0	0	33	62
276	5462 JAGUST W CEREBRAL BLOOD-FLOW AND METABOLISM IN DEMENTIA - REGIONAL PATTERNS AND THE BIOLOGY OF ALZHEIMERS-DISEASE DEVELOPMENTAL BRAIN DYSFUNCTION. 1994 NOV-DEC; 7 (6): 302-310	0	2	33	62
277	7155 Ernst M, Zametkin AJ, Phillips RL, Cohen RM Age-related changes in brain glucose metabolism ia adults with attention-deficit/hyperactivity disorder and control subjects JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 1998 SPR; 10 (2): 168-177	2	28	33	70
278	8130 Mentis MJ Positron emission tomography and single photon emission computed tomography imaging in Alzheimer's disease NEUROLOGIST. 2000 JAN; 6 (1): 28-43	1	1	33	141
279	9067 Kowalska A Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118	1	3	33	81
280	9087 Juengling FD, Kassubek J Nuclear medicine imaging in epilepsy diagnostics Part I: Perfusion and metabolism NERVENHEILKUNDE. 2002; 21 (8): 420-+	0	1	33	60
#	Date / Author / Journal	LCS	GCS	LCR	CR
281	9088 Kassubek J, Juengling FD Nuclear medicine imaging in epilepsy diagnostics part II: receptor diagnostics and functional imaging NERVENHEILKUNDE. 2002; 21 (9): 475-481	0	1	33	63
282	9301 Laruelle M, Slifstein M, Huang YY Positron emission tomography: imaging and neurotransporter availability METHODS. 2002 JUL; 27 (3): 287-299	6	33	33	136
283	9380 Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET NEUROIMAGE. 2002 SEP; 17 (1): 302-316	116	208	33	57
284	9424 Neugroschl J, Davis KL Biological markers in Alzheimer disease AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2002 NOV-DEC; 10 (6): 660-677	0	10	33	269
285	10197 Tsukamoto M, Katoh C, Shiga T, Kaji T, Kuge Y, et al. Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [C-11]flumazenil brain PET EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2004 JUN; 31 (6): 846-851	2	6	33	40
286	10215 Masdeu J Neuroimaging in Alzheimer's disease: An overview REVISTA DE NEUROLOGIA. 2004 JUN 16; 38 (12): 1156-1165	1	2	33	81
287	10315 Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, et al. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies ACTA PSYCHIATRICA SCANDINAVICA. 2004 OCT; 110 (4): 243-256	0	63	33	130
288	10801 Bergmann R, Pietzsch J Small animal positron emission tomography in food sciences AMINO ACIDS. 2005 DEC; 29 (4): 355-376	0	2	33	320
289	11474 Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, et al. Role of PET in the evaluation and understanding of coronary physiology JOURNAL OF NUCLEAR CARDIOLOGY. 2007 JUL-AUG; 14 (4): 589-603	5	12	33	127
290	12053 Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B Nuclear imaging of neuroinflammation: a comprehensive review of [C- 11]PK11195 challengers EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008 DEC; 35 (12): 2304-2319	6	35	33	153
#	Date / Author / Journal	LCS	GCS	LCR	CR
291	12670 Vriens D, Visser EP, de Geus-Oei LF, Oyen WJG Methodological considerations in quantification of oncological FDG PET studies EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010 JUL; 37 (7): 1408-1425	0	1	33	123
292	2958 DEISENHAMMER E, HOLL K 3-DIMENSIONAL SCANNING OF THE BRAIN - SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY (SPECT) WIENER KLINISCHE WOCHENSCHRIFT. 1988 JUN 10; 100 (12): 392-404	4	7	32	105
293	3886 FAULSTICH ME, SULLIVAN DC POSITRON EMISSION TOMOGRAPHY IN NEUROPSYCHIATRY INVESTIGATIVE RADIOLOGY. 1991 FEB; 26 (2): 184-194	2	5	32	93
294	4377 MELON P, SCHWAIGER M IMAGING OF METABOLISM AND AUTONOMIC INNERVATION OF THE HEART BY POSITRON EMISSION TOMOGRAPHY EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1992 JUN; 19 (6): 453-464	1	23	32	101
295	4457 SEDVALL G THE CURRENT STATUS OF PET SCANNING WITH RESPECT TO SCHIZOPHRENIA NEUROPSYCHOPHARMACOLOGY. 1992 AUG; 7 (1): 41-54	12	43	32	73
296	4493 BONNE O, KRAUSZ Y, LERER B SPECT IMAGING IN PSYCHIATRY - A REVIEW GENERAL HOSPITAL PSYCHIATRY. 1992 SEP; 14 (5): 296-306	0	8	32	82
297	5469 JAGUST WJ FUNCTIONAL IMAGING IN DEMENTIA - AN OVERVIEW JOURNAL OF CLINICAL PSYCHIATRY. 1994 NOV; 55: 5-11	6	20	32	74
298	5996 Brooks DJ Functional imaging techniques in the diagnosis of non-Alzheimer dementias JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1996; (47): 155-167	3	5	32	70
299	6450 Magistretti PJ, Pellerin L The contribution of astrocytes to the F-18-2-deoxyglucose signal in PET activation studies MOLECULAR PSYCHIATRY. 1996 DEC; 1 (6): 445-452	9	30	32	91
300	6927 Kegeles LS, Mann JJ In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands NEUROPSYCHOPHARMACOLOGY. 1997 NOV; 17 (5): 293-307	7	27	32	121

Date / Author / Journal

LCS

GCS

LCR

201

12468 Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, et al.

Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (3): 843-854

106

202

951 HEISS WD

EMISSION TOMOGRAPHY OF THE BRAIN

WIENER KLINISCHE WOCHENSCHRIFT. 1981; 93 (12): 371-376

203

3455 ANTAR MA

RADIOPHARMACEUTICALS FOR STUDYING CARDIAC METABOLISM

NUCLEAR MEDICINE AND BIOLOGY. 1990; 17 (1): 103-&

157

204

3713 KUWERT T, LANGE HW, LANGEN KJ, HERZOG H, AULICH A, et al.

CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTONS-DISEASE

BRAIN. 1990 OCT; 113: 1405-1423

153

205

5076 THEODORE WH

INSIGHTS FROM FUNCTIONAL NEUROIMAGING IN THE LOCALIZATION AND DEFINITION OF FOCAL EPILEPSY

CLINICAL NEUROSCIENCE. 1994; 2 (1): 89-95

206

5515 BUCHSBAUM MS

POSITRON EMISSION TOMOGRAPHY STUDIES OF ABNORMAL GLUCOSE-METABOLISM IN SCHIZOPHRENIC ILLNESS

CLINICAL NEUROSCIENCE. 1995; 3 (2): 122-130

207

5769 DEVOUS MD

SPECT FUNCTIONAL BRAIN IMAGING

JOURNAL OF NEUROIMAGING. 1995 JUL; 5: S2-S13

208

6965 Rauch SL, Savage CR

Neuroimaging and neuropsychology of the striatum - Bridging basic science and clinical practice

PSYCHIATRIC CLINICS OF NORTH AMERICA. 1997 DEC; 20 (4): 741-+

193

209

7641 Teipel SJ, Hampel H, Pietrini P, Moller HJ, Rapoport SI

PET in Alzheimer's disease - From resting-state to activation studies

DRUG NEWS & PERSPECTIVES. 1999 MAR; 12 (2): 83-90

210

9766 Asenbaum S

PET and SPECT investigations in Alzheimer's disease

RADIOLOGE. 2003 JUL; 43 (7): 521-+

Date / Author / Journal

LCS

GCS

LCR

211

10305 Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowsey P

PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences

NEUROIMAGE. 2004 SEP; 23 (1): 1-16

198

212

10479 Koepp MJ, Woermann FG

Imaging structure and function in refractory focal epilepsy

LANCET NEUROLOGY. 2005 JAN; 4 (1): 42-53

151

213

10493 D'Souza I, Schellenberg GD

Regulation of tau isoform expression and dementia

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 104-115

117

214

11108 Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, et al.

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2006 SEP; 26 (9): 1198-1212

112

215

11141 Chetelat G, Desgranges B, Eustache F

Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy.

REVUE NEUROLOGIQUE. 2006 OCT; 162 (10): 945-951

216

11344 Kopp MJ

PET tracer technology for monitoring focal epilepsies

EXPERT REVIEW OF MEDICAL DEVICES. 2007 MAR; 4 (2): 191-200

103

217

11686 Herholz K

Imaging of dementia

DISEASES OF THE BRAIN, HEAD & NECK, SPINE. 2008; : 215-218

218

12230 Lalonde L, Ziadi MC, Beanlands R

Cardiac Positron Emission Tomography: Current Clinical Practice

CARDIOLOGY CLINICS. 2009 MAY; 27 (2): 237-+

219

12508 Kim S, Salamon N, Jackson HA, Bluml S, Panigrahy A

PET imaging in pediatric neuroradiology: current and future applications

PEDIATRIC RADIOLOGY. 2010 JAN; 40 (1): 82-96

114

220

2039 CORREIA JA, ALPERT NM

POSITRON EMISSION TOMOGRAPHY IN CARDIOLOGY

RADIOLOGIC CLINICS OF NORTH AMERICA. 1985; 23 (4): 783-793

Date / Author / Journal

LCS

GCS

LCR

221

3752 GZESH D, GOLDSTEIN S, SPERLING MR, ALAVI A

COMPLEX PARTIAL EPILEPSY - THE ROLE OF NEUROIMAGING IN LOCALIZING A SEIZURE FOCUS FOR SURGICAL INTERVENTION

JOURNAL OF NUCLEAR MEDICINE. 1990 NOV; 31 (11): 1839-1843

222

3805 FRISTON KJ, FRACKOWIAK RSJ

CEREBRAL FUNCTION IN AGING AND ALZHEIMERS-DISEASE - THE ROLE OF PET

ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY. 1991; : 355-365

223

3952 SCHWAIGER M, HICKS R

THE CLINICAL ROLE OF METABOLIC IMAGING OF THE HEART BY POSITRON EMISSION TOMOGRAPHY

JOURNAL OF NUCLEAR MEDICINE. 1991 APR; 32 (4): 565-578

111

101

224

3953 GOULD KL

PET PERFUSION IMAGING AND NUCLEAR CARDIOLOGY

JOURNAL OF NUCLEAR MEDICINE. 1991 APR; 32 (4): 579-606

150

225

4042 CLEGHORN JM, ZIPURSKY RB, LIST SJ

STRUCTURAL AND FUNCTIONAL BRAIN IMAGING IN SCHIZOPHRENIA

JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 1991 JUL; 16 (2): 53-74

180

226

4170 WYLER AR

SURGICAL-TREATMENT OF TEMPORAL-LOBE EPILEPSY

NEUROSURGERY QUARTERLY. 1991 DEC; 1 (4): 214-232

154

227

5074 HAWKINS RA, HOH C, GLASPY J, REGE S, CHOI Y, et al.

POSITRON EMISSION TOMOGRAPHY SCANNING IN CANCER

CANCER INVESTIGATION. 1994; 12 (1): 74-87

228

5098 BARON JC

CONSEQUENCES OF LESIONS OF THE BASAL GANGLIA ON BRAIN METABOLIC- ACTIVITY - CLINICAL CORRELATIONS

REVUE NEUROLOGIQUE. 1994; 150 (8-9): 599-604

229

7073 Nguyen DK, Botez MI

Diaschisis and neurobehavior

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 1998 FEB; 25 (1): 5-12

102

230

7517 Inoue O, Kobayashi K, Gee A

Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments

CRITICAL REVIEWS IN NEUROBIOLOGY. 1999; 13 (2): 199-225

191

Date / Author / Journal

LCS

GCS

LCR

231

8315 Gibson RE, Burns HD, Hamill TG, Eng WS, Francis BE, et al.

Non-invasive radiotracer imaging as a tool for drug development

CURRENT PHARMACEUTICAL DESIGN. 2000 JUL; 6 (10): 973-989

117

232

9173 Schmidt KC, Turkheimer FE

Kinetic modeling in positron emission tomography

QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 2002 MAR; 46 (1): 70-85

233

9243 Hutchinson PJ, O'Connell MT, Kirkpatrick PJ, Pickard JD

How can we measure substrate, metabolite and neurotransmitter concentrations in the human brain?

PHYSIOLOGICAL MEASUREMENT. 2002 MAY; 23 (2): R75-R109

264

234

9843 Akanuma N, Koutroumanidis M, Adachi N, Alarcon G, Binnie CD

Presurgical assessment of memory-related brain structures: the Wada test and functional neuroimaging

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2003 SEP; 12 (6): 346-358

135

235

10371 Shiue CY, Welch MJ

Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose

RADIOLOGIC CLINICS OF NORTH AMERICA. 2004 NOV; 42 (6): 1033-+

246

236

10485 Silverman DHS, Alavi A

PET imaging in the assessment of normal and impaired cognitive function

RADIOLOGIC CLINICS OF NORTH AMERICA. 2005 JAN; 43 (1): 67-+

237

11247 Gasparini L, Terni B, Spillantini MG

Frontotemporal dementia with tau pathology

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 236-253

157

238

11725 Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, et al.

Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimers disease

BRAIN. 2008 JAN; 131: 60-71

239

12260 Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, et al.

Amyloid PET and MRI in Alzheimer's Disease and Mild Cognitive Impairment

CURRENT ALZHEIMER RESEARCH. 2009 JUN; 6 (3): 312-319

240

12613 Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, et al.

Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages

BRAIN STRUCTURE & FUNCTION. 2010 MAY; 214 (4): 303-317

Date / Author / Journal

LCS

GCS

LCR

241

2549 SCHELBERT HR, SCHWAIGER M

POSITRON EMISSION TOMOGRAPHY IN HUMAN MYOCARDIAL-ISCHEMIA

HERZ. 1987 FEB; 12 (1): 22-40

242

2923 HENDEE WR

APPLICATION OF POSITRON EMISSION TOMOGRAPHY IN THE HEART

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1988 APR 22; 259 (16): 2438-2445

243

5334 WITTE OW, BRUEHL C, SCHLAUG G, TUXHORN I, LAHL R, et al.

DYNAMIC CHANGES OF FOCAL HYPOMETABOLISM IN RELATION TO EPILEPTIC ACTIVITY

JOURNAL OF THE NEUROLOGICAL SCIENCES. 1994 JUL; 124 (2): 188-197

244

5558 GAILLARD WD, WHITE S, MALOW B, FLAMINI R, WEINSTEIN S, et al.

FDG-PET IN CHILDREN AND ADOLESCENTS WITH PARTIAL SEIZURES - ROLE IN EPILEPSY SURGERY EVALUATION

EPILEPSY RESEARCH. 1995 JAN; 20 (1): 77-84

245

6024 Camici PG, Gropler RJ, Jones T, LAbbate A, Maseri A, et al.

The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases

EUROPEAN HEART JOURNAL. 1996 JAN; 17 (1): 25-34

246

7113 Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, et al.

Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: Analysis of the FDG lumped constant

JOURNAL OF NUCLEAR MEDICINE. 1998 MAR; 39 (3): 440-448

247

8513 Forman MS, Lee VMY, Trojanowski JQ

New insights into genetic and molecular mechanisms of brain degeneration in tauopathies

JOURNAL OF CHEMICAL NEUROANATOMY. 2000 DEC; 20 (3-4): 225-244

191

248

9159 Langer O, Halldin C

PET and SPET tracers for mapping the cardiac nervous system

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2002 MAR; 29 (3): 416-434

193

249

10077 Bartenstein P

PET in neuroscience - Dopaminergic, GABA/benzodiazepine, and opiate system

NUKLEARMEDIZIN-NUCLEAR MEDICINE. 2004 FEB; 43 (1): 33-42

121

250

10495 Brandt R, Hundelt M, Shahani N

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 331-354

228

Date / Author / Journal

LCS

GCS

LCR

251

10568 Ito H, Kanno I, Fukuda H

Human cerebral circulation: positron emission tomography studies

ANNALS OF NUCLEAR MEDICINE. 2005 APR; 19 (2): 65-74

136

252

10850 Eckelman WC

Imaging of muscarinic receptors in the central nervous system

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (30): 3901-3913

108

253

10923 Slart RHJA, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RAJO, et al.

Imaging techniques in nuclear cardiology for the assessment of myocardial viability

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING. 2006 FEB; 22 (1): 63-80

137

254

12216 Borghammer P, Cumming P, Aanerud J, Gjedde A

Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

NEUROIMAGE. 2009 APR 1; 45 (2): 249-257

255

2383 FEENEY DM, BARON JC

DIASCHISIS

STROKE. 1986 SEP-OCT; 17 (5): 817-830

125

508

206

256

3035 MAURER AH

NUCLEAR-MEDICINE - SPECT COMPARISONS TO PET

RADIOLOGIC CLINICS OF NORTH AMERICA. 1988 SEP; 26 (5): 1059-1074

257

3134 TEWSON TJ

PROCEDURES, PITFALLS AND SOLUTIONS IN THE PRODUCTION OF [F-18]2-DEOXY- 2-FLUORO-D-GLUCOSE - A PARADIGM IN THE ROUTINE SYNTHESIS OF F-18 RADIOPHARMACEUTICALS

NUCLEAR MEDICINE AND BIOLOGY. 1989; 16 (6): 533-551

258

5470 MAYBERG HS

CLINICAL CORRELATES OF PET-IDENTIFIED AND SPECT-IDENTIFIED DEFECTS IN DEMENTIA

JOURNAL OF CLINICAL PSYCHIATRY. 1994 NOV; 55: 12-21

259

8298 Brinkmann BH, O'Brien TJ, Mullan BP, O'Connor MK, Robb RA, et al.

Subtraction ictal SPECT coregistered to MRI for seizure focus localization in partial epilepsy

MAYO CLINIC PROCEEDINGS. 2000 JUN; 75 (6): 615-624

104

260

9327 Salmon E

Functional brain imaging applications to differential diagnosis in the dementias

CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 439-444

Date / Author / Journal

LCS

GCS

LCR

261

9968 Shinotoh H, Fukushi K, Nagatsuka S, Irie T

Acetylcholinesterase imaging: Its use in therapy evaluation and drug design

CURRENT PHARMACEUTICAL DESIGN. 2004; 10 (13): 1505-1517

262

10094 Farias ST, Jagust WJ

Neuroimaging in non-Alzheimer dementias

CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 383-395

133

263

10552 Pakrasi S, O'Brien JT

Emission tomography in dementia

NUCLEAR MEDICINE COMMUNICATIONS. 2005 MAR; 26 (3): 189-196

102

264

11180 Hammers A, Lingford-Hughes A

Opioid imaging

NEUROIMAGING CLINICS OF NORTH AMERICA. 2006 NOV; 16 (4): 529-+

135

265

11481 Cohen RM

The application of positron-emitting molecular imaging tracers in Alzheimer's disease

MOLECULAR IMAGING AND BIOLOGY. 2007 JUL-AUG; 9 (4): 204-216

130

266

12132 Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, et al.

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging

NEUROIMAGE. 2009 JAN 1; 44 (1): 43-50

267

12231 Schelbert HR

Quantification of Myocardial Blood Flow: What is the Clinical Role?

CARDIOLOGY CLINICS. 2009 MAY; 27 (2): 277-+

268

12309 Borghammer P, Aanerud J, Gjedde A

Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization

NEUROIMAGE. 2009 JUL 15; 46 (4): 981-988

269

12416 Saft C, Kosinski CM, Landwehrmeyer GB

Progress in Premanifest and Manifest Diagnostics in Huntington's Disease

AKTUELLE NEUROLOGIE. 2009 DEC; 36 (10): 506-+

250

270

12439 Tateno M, Kobayashi S, Saito T

Imaging Improves Diagnosis of Dementia with Lewy Bodies

PSYCHIATRY INVESTIGATION. 2009 DEC; 6 (4): 233-240

Date / Author / Journal

LCS

GCS

LCR

271

12766 Schweitzer PJ, Fallon BA, Mann JJ, Kumar JSD

PET tracers for the peripheral benzodiazepine receptor and uses thereof

DRUG DISCOVERY TODAY. 2010 NOV; 15 (21-22): 933-942

272

3502 LEENDERS KL, PERANI D, LAMMERTSMA AA, HEATHER JD, BUCKINGHAM P, et al.

CEREBRAL BLOOD-FLOW, BLOOD-VOLUME AND OXYGEN UTILIZATION - NORMAL VALUES AND EFFECT OF AGE

BRAIN. 1990 FEB; 113: 27-47

440

273

4551 VOLKOW ND, FOWLER JS

NEUROPSYCHIATRIC DISORDERS - INVESTIGATION OF SCHIZOPHRENIA AND SUBSTANCE-ABUSE

SEMINARS IN NUCLEAR MEDICINE. 1992 OCT; 22 (4): 254-267

274

5103 HOH CK, DAHLBOM M, HAWKINS RA, GLASPY JA, YAO WJ, et al.

BASIC PRINCIPLES OF POSITRON EMISSION TOMOGRAPHY IN ONCOLOGY - QUANTITATION AND WHOLE-BODY TECHNIQUES

WIENER KLINISCHE WOCHENSCHRIFT. 1994; 106 (15): 496-504

102

275

5374 MOERLEIN SM, PERLMUTTER JS, WELCH MJ, RAICHLE ME

FIRST-PASS EXTRACTION FRACTION OF I-123 LABELED PERFUSION TRACERS IN LIVING PRIMATE BRAIN

NUCLEAR MEDICINE AND BIOLOGY. 1994 AUG; 21 (6): 847-855

276

5462 JAGUST W

CEREBRAL BLOOD-FLOW AND METABOLISM IN DEMENTIA - REGIONAL PATTERNS AND THE BIOLOGY OF ALZHEIMERS-DISEASE

DEVELOPMENTAL BRAIN DYSFUNCTION. 1994 NOV-DEC; 7 (6): 302-310

277

7155 Ernst M, Zametkin AJ, Phillips RL, Cohen RM

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 1998 SPR; 10 (2): 168-177

278

8130 Mentis MJ

Positron emission tomography and single photon emission computed tomography imaging in Alzheimer's disease

NEUROLOGIST. 2000 JAN; 6 (1): 28-43

141

279

9067 Kowalska A

Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118

280

9087 Juengling FD, Kassubek J

Nuclear medicine imaging in epilepsy diagnostics Part I: Perfusion and metabolism

NERVENHEILKUNDE. 2002; 21 (8): 420-+

Date / Author / Journal

LCS

GCS

LCR

281

9088 Kassubek J, Juengling FD

Nuclear medicine imaging in epilepsy diagnostics part II: receptor diagnostics and functional imaging

NERVENHEILKUNDE. 2002; 21 (9): 475-481

282

9301 Laruelle M, Slifstein M, Huang YY

Positron emission tomography: imaging and neurotransporter availability

METHODS. 2002 JUL; 27 (3): 287-299

136

283

9380 Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, et al.

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

NEUROIMAGE. 2002 SEP; 17 (1): 302-316

116

208

284

9424 Neugroschl J, Davis KL

Biological markers in Alzheimer disease

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2002 NOV-DEC; 10 (6): 660-677

269

285

10197 Tsukamoto M, Katoh C, Shiga T, Kaji T, Kuge Y, et al.

Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [C-11]flumazenil brain PET

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2004 JUN; 31 (6): 846-851

286

10215 Masdeu J

Neuroimaging in Alzheimer's disease: An overview

REVISTA DE NEUROLOGIA. 2004 JUN 16; 38 (12): 1156-1165

287

10315 Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, et al.

Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies

ACTA PSYCHIATRICA SCANDINAVICA. 2004 OCT; 110 (4): 243-256

130

288

10801 Bergmann R, Pietzsch J

Small animal positron emission tomography in food sciences

AMINO ACIDS. 2005 DEC; 29 (4): 355-376

320

289

11474 Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, et al.

Role of PET in the evaluation and understanding of coronary physiology

JOURNAL OF NUCLEAR CARDIOLOGY. 2007 JUL-AUG; 14 (4): 589-603

127

290

12053 Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B

Nuclear imaging of neuroinflammation: a comprehensive review of [C- 11]PK11195 challengers

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008 DEC; 35 (12): 2304-2319

153

Date / Author / Journal

LCS

GCS

LCR

291

12670 Vriens D, Visser EP, de Geus-Oei LF, Oyen WJG

Methodological considerations in quantification of oncological FDG PET studies

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010 JUL; 37 (7): 1408-1425

123

292

2958 DEISENHAMMER E, HOLL K

3-DIMENSIONAL SCANNING OF THE BRAIN - SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY (SPECT)

WIENER KLINISCHE WOCHENSCHRIFT. 1988 JUN 10; 100 (12): 392-404

105

293

3886 FAULSTICH ME, SULLIVAN DC

POSITRON EMISSION TOMOGRAPHY IN NEUROPSYCHIATRY

INVESTIGATIVE RADIOLOGY. 1991 FEB; 26 (2): 184-194

294

4377 MELON P, SCHWAIGER M

IMAGING OF METABOLISM AND AUTONOMIC INNERVATION OF THE HEART BY POSITRON EMISSION TOMOGRAPHY

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1992 JUN; 19 (6): 453-464

101

295

4457 SEDVALL G

THE CURRENT STATUS OF PET SCANNING WITH RESPECT TO SCHIZOPHRENIA

NEUROPSYCHOPHARMACOLOGY. 1992 AUG; 7 (1): 41-54

296

4493 BONNE O, KRAUSZ Y, LERER B

SPECT IMAGING IN PSYCHIATRY - A REVIEW

GENERAL HOSPITAL PSYCHIATRY. 1992 SEP; 14 (5): 296-306

297

5469 JAGUST WJ

FUNCTIONAL IMAGING IN DEMENTIA - AN OVERVIEW

JOURNAL OF CLINICAL PSYCHIATRY. 1994 NOV; 55: 5-11

298

5996 Brooks DJ

Functional imaging techniques in the diagnosis of non-Alzheimer dementias

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1996; (47): 155-167

299

6450 Magistretti PJ, Pellerin L

The contribution of astrocytes to the F-18-2-deoxyglucose signal in PET activation studies

MOLECULAR PSYCHIATRY. 1996 DEC; 1 (6): 445-452

300

6927 Kegeles LS, Mann JJ

In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands

NEUROPSYCHOPHARMACOLOGY. 1997 NOV; 17 (5): 293-307

121

DE Kuhl w/citing papers Publications by DE Kuhl and the papers citing DE Kuhl	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 111881, GCS 497938, CR 637448 Collection span: 1956 - 2011
List of All Records